Scientists explain a key difference between the spike-protein molecules generated by the SARS-CoV-2 mRNA vaccine and those the virus induces.
Researchers at Stanford Medicine explore a potentially causative connection between a blood disorder and Alzheimer's.
Stanford Medicine experts discuss the past successes and future potential of mRNA as a new type of medicine or treatment.
Purvesh Khatri has followed a winding path to medicine -- one that started with a hate for biology and a career in engineering.
Researchers at Stanford are devising new ways to deliver mRNA to the body to facilitate more potent and accurate treatments and vaccines.
This is Part I in a series that will explore the promise, challenges and future of mRNA. Let's count our blessings. The COVID-19 pandemic, from …
Two Stanford Medicine dermatology experts weigh in on the possible allergies associated with "natural" skincare products.
Stanford pathologist speaks to the likelihood of undetectable COVID-19 and best practices for staying safe in the face of uncertainty.
By harnessing an antibody most overlooked, researchers devise a new possible way to stop viruses, even as they evolve.
Stanford Medicine magazine explores the molecules behind human biology and how understanding them fuels medical discoveries and innovations.
Stanford experts discuss what ‘endemic’ means in the context of biology, masking, vaccines, and mental and behavioral health.
Tobacco smoke blocks airway cells from making a protein that protects against infection by the virus that causes COVID-19.
Neurosurgeon Michael Lim studies how to unleash the immune system to attack a type of brain cancer called glioblastoma.
A common ovarian cancer evades detection by convincing nearby immune cells to treat it as a developing fetus.
A Stanford pediatric infectious disease expert is highlighted in a new campaign to answer parents' questions about COVID-19 vaccines.
A new way to deliver mRNA as a COVID-19 vaccine may avoid side effects and increase customization to prevent infection.
